Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Bicycle Therapeutics (BCYC) over the last 3 years, with Q3 2025 value amounting to -$2.5 million.

  • Bicycle Therapeutics' Other Operating Expenses rose 229.16% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.6 million, marking a year-over-year decrease of 4818.2%. This contributed to the annual value of -$9.0 million for FY2024, which is 98.5% up from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Other Operating Expenses is -$2.5 million, which was up 229.16% from -$2.3 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Other Operating Expenses ranged from a high of -$1.9 million in Q2 2024 and a low of -$2.6 million during Q4 2024